Asia Pacific Pharmaceutical Third-party Logistics (3pl) Market Size & Outlook

The pharmaceutical third-party logistics (3pl) market in Asia Pacific is expected to reach a projected revenue of US$ 50,573.1 million by 2030. A compound annual growth rate of 11.1% is expected of Asia Pacific pharmaceutical third-party logistics (3pl) market from 2025 to 2030.
Revenue, 2024 (US$M)
$27,154.7
Forecast, 2030 (US$M)
$50,573.1
CAGR, 2025 - 2030
11.1%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific pharmaceutical third-party logistics (3pl) market, 2018-2030 (US$M)

Asia Pacific pharmaceutical third-party logistics (3pl) market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Asia Pacific pharmaceutical third-party logistics (3pl) market highlights

  • The Asia Pacific pharmaceutical third-party logistics (3pl) market generated a revenue of USD 27,154.7 million in 2024.
  • The market is expected to grow at a CAGR of 10.9% from 2025 to 2030.
  • In terms of segment, branded was the largest revenue generating product type in 2024.
  • Cell Therapy is the most lucrative product type segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2030.


Asia Pacific data book summary

Market revenue in 2024USD 27,154.7 million
Market revenue in 2030USD 50,573.1 million
Growth rate10.9% (CAGR from 2025 to 2030)
Largest segmentBranded
Fastest growing segmentCell Therapy
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBranded, Generic, Biosimilar, Vaccine, Cell Therapy, Gene Therapy


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 19.8% of the global pharmaceutical third-party logistics (3pl) market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 50,573.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmaceutical Third-Party Logistics (3PL) Market Companies

Name Profile # Employees HQ Website
Knipper View profile 11-50 Saarbrücken, Saarland, Germany, Europe https://knipper.de
Kuehne + Nagel View profile 10001+ Schönefeld, Brandenburg, Germany, Europe https://home.kuehne-nagel.com/
McKesson Corporation View profile - - -
Cardinal Health View profile - - -
EVERSANA View profile 5001-10000 Milwaukee, Wisconsin, United States, North America https://www.eversana.com
CEVA Logistics View profile 10001+ Marseille, Provence-Alpes-Cote d'Azur, France, Europe https://www.cevalogistics.com/
DB Schenker View profile 10001+ Essen, Nordrhein-Westfalen, Germany, Europe https://www.dbschenker.com/global
Cencora Inc View profile 46000 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 https://www.cencora.com
Kerry Logistics Network Ltd View profile 33100 55 Wing Kei Road, 16th Floor, Kerry Cargo Centre, New Territories, Kwai Chung, Hong Kong, Hong Kong, https://www.kln.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Asia Pacific pharmaceutical third-party logistics (3pl) market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical third-party logistics (3pl) market will help companies and investors design strategic landscapes.


Branded was the largest segment with a revenue share of 39.1% in 2024. Horizon Databook has segmented the Asia Pacific pharmaceutical third-party logistics (3pl) market based on branded, generic, biosimilar, vaccine, cell therapy, gene therapy covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Asia Pacific pharmaceutical third-party logistics (3pl) market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific pharmaceutical third-party logistics (3pl) market databook

  • Our clientele includes a mix of pharmaceutical third-party logistics (3pl) market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific pharmaceutical third-party logistics (3pl) market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific pharmaceutical third-party logistics (3pl) market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific pharmaceutical third-party logistics (3pl) market size, by country, 2018-2030 (US$M)

Asia Pacific Pharmaceutical Third-Party Logistics (3PL) Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific pharmaceutical third-party logistics (3pl) market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online